Serveur d'exploration Tocilizumab - Curation (Accueil)

Index « AffRegInc.i » - entrée « Ibaraki »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Iasi < Ibaraki < Ibaraki  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
001E94 (2015) Atsushi Ogata [Japon] ; Tatsuya Atsumi [Japon] ; Takaaki Fukuda [Japon] ; Yasuhiko Hirabayashi [Japon] ; Masaaki Inaba [Japon] ; Naoki Ishiguro [Japon] ; Motokazu Kai [Japon] ; Daisuke Kawabata [Japon] ; Daihei Kida [Japon] ; Hitoshi Kohsaka [Japon] ; Ryutaro Matsumura [Japon] ; Seiji Minota [Japon] ; Masaya Mukai [Japon] ; Takayuki Sumida [Japon] ; Kiyoshi Takasugi [Japon] ; Shigenori Tamaki [Japon] ; Tsutomu Takeuchi [Japon] ; Atsuhisa Ueda [Japon] ; Kazuhiko Yamamoto [Japon] ; Hisashi Yamanaka [Japon] ; Hajime Yoshifuji [Japon] ; Akira Nomura [Japon]Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis.
002158 (2015) Takeshi Suzuki [Japon] ; Tomoya Hirota [Japon] ; Hiroshi Ogishima [Japon] ; Naoto Umeda [Japon] ; Yuya Kondo [Japon] ; Masahiro Yokosawa [Japon] ; Haruka Miki [Japon] ; Hiroto Tsuboi [Japon] ; Isao Matsumoto [Japon] ; Takayuki Sumida [Japon]Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for 2 years
002574 (2014) Shuji Ohta [Japon] ; Tomomi Tsuru [Japon] ; Kimio Terao [Japon] ; Seiji Mogi [Japon] ; Midori Suzaki [Japon] ; Eisuke Shono [Japon] ; Yoshimasa Ishida [Japon] ; Eriko Tarumi [Japon] ; Masato Imai [Japon]Mechanism‐based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study)
002F51 (2013) Masatoshi Inagaki [Japon] ; Tatsuo Akechi [Japon] ; Toru Okuyama [Japon] ; Yuriko Sugawara [Japon] ; Hiroya Kinoshita [Japon] ; Yasuo Shima [Japon] ; Kimio Terao [Japon] ; Shuichi Mitsunaga [Japon] ; Atsushi Ochiai [Japon] ; Yosuke Uchitomi [Japon]Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients
002F71 (2013) M. Sugihara ; Y. Okamoto [Japon] ; T. Hirota ; T. Suzuki ; M. Horikoshi ; C. Hagiya ; H. Miki ; M. Yokosawa ; S. Hagiwara ; Y. Takano ; N. Umeda ; Y. Kondo ; H. Tsuboi ; H. Ogishima ; T. Hayashi ; Y. Chino ; D. Goto ; I. Matsumoto ; T. SumidaAB1281 Making a diagnosis and predicting prognosis of bone structure by low field compact magnetic resonance imaging machine in patients with rheumatoid arthritis
003287 (2013) H. Yoshida ; M. Suzuki ; K. Tanaka ; M. Hashizume ; M. Shiina ; I. Matsumoto [Japon] ; T. Sumida [Japon] ; M. MiharaAB0158 Anti-interleukin-6 receptor antibody suppresses loss of trabecular bone volume in mice with glucose-6-phosphate isomerase-induced arthritis
003A75 (2011) Masahiro Iwamoto [Japon] ; Sumiko Homma [Japon] ; Sachiko Onishi [Japon] ; Yasuyuki Kamata [Japon] ; Katsuya Nagatani [Japon] ; Zentaro Yamagata [Japon] ; Seiji Minota [Japon]Low level of seroconversion after a novel influenza A/H1N1/2009 vaccination in Japanese patients with rheumatoid arthritis in the 2009 season
003B98 (2011) Kazuki Yoshida [Japon] ; Yasuharu Tokuda [Japon] ; Hideto Oshikawa [Japon] ; Masako Utsunomiya [Japon] ; Tatsuo Kobayashi [Japon] ; Makiko Kimura [Japon] ; Gautam A. Deshpande [Japon] ; Kazuo Matsui [Japon] ; Mitsumasa Kishimoto [Japon]An observational study of tocilizumab and TNF-α inhibitor use in a Japanese community hospital: different remission rates, similar drug survival and safety
003D48 (2010) A. Asahina [Japon] ; N. Sakurai [Japon] ; Y. Suzuki [Japon] ; K. Narushima [Japon]Schnitzler’s syndrome with prominent neutrophil infiltration misdiagnosed as Sweet’s syndrome: a typical example of urticarial neutrophilic dermatosis
003D89 (2010) Masahiro Iwamoto [Japon] ; Sumiko Honma [Japon] ; Yasushi Asano [Japon] ; Seiji Minota [Japon]Effective and safe administration of tocilizumab to a patient with rheumatoid arthritis on haemodialysis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffRegInc.i -k "Ibaraki" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/AffRegInc.i  \
                -Sk "Ibaraki" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    AffRegInc.i
   |clé=    Ibaraki
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021